Fonte: Journal of Antimicrobial Chemotherapy. Unidades: FCF, IQ
Assuntos: CANDIDA, MICROBIOLOGIA MÉDICA
ABNT
LINCOPAN, Nilton e MAMIZUKA, Elsa Masae e CARMONA-RIBEIRO, Ana Maria. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. Journal of Antimicrobial Chemotherapy, v. 52, n. 3, p. 412-418, 2003Tradução . . Disponível em: https://doi.org/10.1093/jac/dkg383. Acesso em: 10 nov. 2024.APA
Lincopan, N., Mamizuka, E. M., & Carmona-Ribeiro, A. M. (2003). In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments. Journal of Antimicrobial Chemotherapy, 52( 3), 412-418. doi:10.1093/jac/dkg383NLM
Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments [Internet]. Journal of Antimicrobial Chemotherapy. 2003 ; 52( 3): 412-418.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jac/dkg383Vancouver
Lincopan N, Mamizuka EM, Carmona-Ribeiro AM. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments [Internet]. Journal of Antimicrobial Chemotherapy. 2003 ; 52( 3): 412-418.[citado 2024 nov. 10 ] Available from: https://doi.org/10.1093/jac/dkg383